Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Rademann 2017 Oxid Med Cell Longev

From Bioblast
Revision as of 12:16, 26 June 2019 by Krumschnabel Gerhard (talk | contribs)
(diff) โ† Older revision | Latest revision (diff) | Newer revision โ†’ (diff)
Publications in the MiPMap
Rademann P, Weidinger A, Drechsler S, Meszaros A, Zipperle J, Jafarmadar M, Dumitrescu S, Hacobian A, Ungelenk L, Rรถstel F, Kaszaki J, Szabo A, Skulachev VP, Bauer M, Bahrami S, Weis S, Kozlov AV, Osuchowski MF (2017) Mitochondria-targeted antioxidants SKQ1 and MitoTEMPO failed to exert a long-term beneficial effect in murine polymicrobial sepsis. Oxid Med Cell Longev 6412682.

ยป Open Access

Rademann P, Weidinger A, Drechsler S, Meszaros A, Zipperle J, Jafarmadar M, Dumitrescu S, Hacobian A, Ungelenk L, Roestel F, Kaszaki J, Szabo A, Skulachev VP, Bauer M, Bahrami S, Weis S, Kozlov AV, Osuchowski MF (2017) Oxid Med Cell Longev

Abstract: Mitochondrial-derived reactive oxygen species have been deemed an important contributor in sepsis pathogenesis. We investigated whether two mitochondria-targeted antioxidants (mtAOX; SkQ1 and MitoTEMPO) improved long-term outcome, lessened inflammation and improved organ homeostasis in polymicrobial murine sepsis.

3-month-old female CD-1 mice (n=90) underwent cecal ligation and puncture (CLP) and were administered SkQ1 (5nmol/kg), MitoTEMPO (50nmol/kg) or vehicle 5 times post-CLP. Separately, 52 SkQ1-treated CLP mice were sacrificed at 24h and 48h for additional endpoints.

Neither MitoTEMPO nor SkQ1 exerted any protracted survival benefit. Conversely, SkQ1 exacerbated 28-day mortality by 29%. CLP induced release of 10 circulating cytokines and increased tissue damage/dysfunction markers (urea, ALT, LDH, glucose) but irrespectively of treatment. Similar occurred for CLP-induced lymphopenia/neutrophilia and the NO blood release. At 48h post-CLP, dying mice had approximately 100-fold more CFUs in the spleen than survivors, but this was not SkQ1-related. At 48h, macrophage and granulocyte counts increased in the peritoneal lavage but irrespectively of SkQ1. Similarly, hepatic mitophagy was not altered by SkQ1 at 24h.

The absence of survival benefit of mtAOX may be due to the extended treatment and/or a relatively moderate-risk-of-death CLP cohort. Long-term effect of mtAOX in abdominal sepsis appears different to sepsis/inflammation models arising from other body compartments. โ€ข Keywords: Mitochondria-targeted, SkQ1, MitoTEMPO, CLP, Outcome โ€ข Bioblast editor: Kandolf G, Meszaros A โ€ข O2k-Network Lab: AT Vienna Kozlov AV, HU Szeged Boros M, RU Moscow Skulachev VP


Labels: MiParea: Respiration, mt-Medicine, Pharmacology;toxicology  Pathology: Sepsis  Stress:Oxidative stress;RONS  Organism: Mouse, Rat  Tissue;cell: Liver  Preparation: Homogenate 

Regulation: Inhibitor  Coupling state: OXPHOS  Pathway:HRR: Oxygraph-2k 

2017-08